| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/12/2006 | EP1075261B1 Mycobacterial inhibitors |
| 04/12/2006 | EP1071431B1 Cosmetic formulations comprising bis(triorganosilyl)hydroxycarboxylic acid derivatives |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP1041880A4 A delivery of arginine to cause beneficial effects |
| 04/12/2006 | EP1039897B1 Inadone and tetralone compounds for inhibiting cell proliferation |
| 04/12/2006 | EP1032555B1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 04/12/2006 | EP1009387B1 Stabilized sustained release tramadol formulations |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP0912179B1 Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
| 04/12/2006 | EP0861319B1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN2770657Y Superficial vein exposed painless puncture plaster |
| 04/12/2006 | CN1759182A Compositions and systems for the regulation of genes |
| 04/12/2006 | CN1759176A Diagnosis and treatment of multiple sulfatase deficiency andother sulfatase deficiencies using a formylglycine generating enzyme (FGE) |
| 04/12/2006 | CN1759118A Diazepinoindole derivatives as kinase inhibitors |
| 04/12/2006 | CN1759116A Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 04/12/2006 | CN1759115A Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 04/12/2006 | CN1759114A Heterocyclic N-aryl carboxamides as cytokine inhibitors |
| 04/12/2006 | CN1759112A Benzimidazole derivatives and their use for modulating the GABA- SB A /SB receptor complex |
| 04/12/2006 | CN1759111A Imidazol-4-yl-ethynyl-pyridine derivatives |
| 04/12/2006 | CN1759110A Pyrazole derivative |
| 04/12/2006 | CN1759109A Substituted benzoylureidopyridyl-piperidine and -pyrrolidinecarboxylic acid derivatives, method for the production thereof and the use thereof |
| 04/12/2006 | CN1759108A Biphenyl derivatives |
| 04/12/2006 | CN1759104A Non-nucleoside reverse transcriptase inhibitors I for treating HIV mediated diseases |
| 04/12/2006 | CN1759103A Water-soluble phenylpyridazine derivative and medicine containing the same |
| 04/12/2006 | CN1759101A Quinolinone / benzoxazinone derivatives and uses thereof |
| 04/12/2006 | CN1759099A Substituted aniline derivatives |
| 04/12/2006 | CN1759097A Chemical process for the preparation of intermediates to obtain N-formyl hydroxylamine compounds |
| 04/12/2006 | CN1759095A N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 04/12/2006 | CN1758924A Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy |
| 04/12/2006 | CN1758921A Storage-stable and bio-stable formulations of ACE inhibitors, and methods for preparation thereof |
| 04/12/2006 | CN1758920A Cystitis treatment with high dose chondroitin sulfate |
| 04/12/2006 | CN1758919A Compositions comprising hyaluronic acid for the prevention of urogenital infections |
| 04/12/2006 | CN1758918A Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs |
| 04/12/2006 | CN1758917A Flavanols and procyanidins promote homeostasis |
| 04/12/2006 | CN1758916A Method of treating and preventing hyperparathyroidism with vitamin D2 or D4 compounds |
| 04/12/2006 | CN1758915A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 04/12/2006 | CN1758914A Treatment of excessive osteolyisis with indolinone compounds |
| 04/12/2006 | CN1758913A Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 04/12/2006 | CN1758912A Therapeutic agents for drug/substance dependence |
| 04/12/2006 | CN1758911A Liquid pharmaceutical formulations of palonosetron |
| 04/12/2006 | CN1758910A Use of isoquinoline derivatives for treating cancer and MAP kinase related diseases |
| 04/12/2006 | CN1758909A Substituted piperidines as novel MDM2-p53 inhibitors |
| 04/12/2006 | CN1758908A Treatment of proliferative diseases with epothilone derivatives and radiation |
| 04/12/2006 | CN1758907A Amino acid phenoxy ethers |
| 04/12/2006 | CN1758906A Compositions for the improvement of obesity |
| 04/12/2006 | CN1758905A Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 04/12/2006 | CN1758904A Non-steroidal anti-inflammatory drug dosing regimen |
| 04/12/2006 | CN1758903A Enteric sustained-release fine particles for tamsulosin or its salt and process for producing the same |
| 04/12/2006 | CN1758893A Composition comprising particulate zinc materials having a defined crystallite size |
| 04/12/2006 | CN1757743A Isoflavone-containing composition |
| 04/12/2006 | CN1757646A Inhibitors of nucleoside metabolism |
| 04/12/2006 | CN1757637A Method for purifying VE nicotinate raw material |
| 04/12/2006 | CN1757622A 2-hydroxy-3-alkoxypropyl sulfides, sulfones, and sulfoxides: new surface active agents |
| 04/12/2006 | CN1757414A Method for preparing visible polysaccharide membrane used as carrier of medicine for treating eye surface diseases |
| 04/12/2006 | CN1757409A Recipe of Wanshou capsule, and health-care function |
| 04/12/2006 | CN1757407A Traditional Chinese medicine pills for treating toothache, and its prepn. method |
| 04/12/2006 | CN1757398A Method for preparing inorganic salt nanometer particles containing and packing traditional Chinese medicine and its application |
| 04/12/2006 | CN1757394A Multi-unit slow-release preparation |
| 04/12/2006 | CN1757393A Fosfocina calcium disperser, and its prepn. method |
| 04/12/2006 | CN1757392A Cream for treating dexmatosis, and its prepn. method |
| 04/12/2006 | CN1757391A Application of neutral berberine sulfate for preparing medicine to treat and prepvent endotoxic diseases |
| 04/12/2006 | CN1757390A Obtundent-Tilidin hydrochloride preparation |
| 04/12/2006 | CN1757389A Implanted agent for preventing and treating biabetic retinopathy |
| 04/12/2006 | CN1757388A Multi-unit slow-releasing preparation |
| 04/12/2006 | CN1250732C 病毒株 Strains |
| 04/12/2006 | CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 04/12/2006 | CN1250563C Androgen glycosides and androgenic activity thereof |
| 04/12/2006 | CN1250559C Process for preparing amine platinum complexes |
| 04/12/2006 | CN1250553C Antidepressant azaheterocyclylmethyl derivatives of 2, 3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 04/12/2006 | CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/12/2006 | CN1250549C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 04/12/2006 | CN1250548C Novel adenine derivatives |
| 04/12/2006 | CN1250546C Tetrahydropyrido compound |
| 04/12/2006 | CN1250545C Quinuclidine derivatives and medicine composition containing the derivatives |
| 04/12/2006 | CN1250544C Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods |
| 04/12/2006 | CN1250542C 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 04/12/2006 | CN1250541C Amorphous form of cell cycle inhibitor |
| 04/12/2006 | CN1250536C 4-aminobenzopyran derivatives |
| 04/12/2006 | CN1250533C Novel azoles having an insecticidal action |
| 04/12/2006 | CN1250531C Novel compounds |
| 04/12/2006 | CN1250529C Rosinyl acridine its producing method and use thereof |
| 04/12/2006 | CN1250528C Cyclic nitrones and pharmaceutical compositions containing them |
| 04/12/2006 | CN1250526C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 04/12/2006 | CN1250521C Acetyl l-carnitine salt and process for preparing same |
| 04/12/2006 | CN1250312C Formation of small crystals |
| 04/12/2006 | CN1250295C Magnetism and drug combined type fragrant baldric for avoiding plague |
| 04/12/2006 | CN1250294C Photosensitive and method for production thereof |
| 04/12/2006 | CN1250293C Drug composites |
| 04/12/2006 | CN1250292C Freeze-dried pantoprazole preparation and pantoprazole injection |
| 04/12/2006 | CN1250291C Stabilised pharmaceutical compositions and process for their preparation comprising antibiotic and expectorant |
| 04/12/2006 | CN1250290C Novel medicament compositions, based on anticholinergic effective compounds and beta-mimetiques |
| 04/12/2006 | CN1250289C Drugs, drinks or foods |
| 04/12/2006 | CN1250286C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/12/2006 | CN1250283C Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 04/12/2006 | CN1250281C Method for treating endothelium wound |
| 04/12/2006 | CN1250279C Liposome targeting of matrix metalloproteinase inhibitors |
| 04/12/2006 | CN1250265C Composition for treating osteoporosis |
| 04/12/2006 | CN1250259C Liquid medicine for treating burns |
| 04/12/2006 | CN1250254C Medicine for promoting wound healing |